Elevation Oncology Inc Live Share Price Today, Share Analysis and Chart

Name: Elevation Oncology Inc: Is Infosys Ltd. worth buying?
Item: Elevation Oncology Inc
Rating: 1.34058325
Author: Trendlyne DVM scores

about

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an...

0.38 0.00 (0.00%)

88.41% Fall from 52W High

426.9K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.8 / 100

Technically Neutral

38.8 / 100

No estimates available

Elevation Oncology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Elevation Oncology Inc Live Share Price Today, Share Analysis and Chart

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an...

88.41% Fall from 52W High

SWOT Analysis

Elevation Oncology Inc Live Price Chart